Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model

Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model

Various combination treatments have been considered to attain the effective therapy threshold by combining independent antitumor mechanisms against the heterogeneous characteristics of tumor cells in malignant brain tumors. In this study, the natural killer (NK) cells associated with bevacizumab (Be...

Full description

Bibliographic Details
Main Authors: Thi-Anh-Thuy Tran, Young-Hee Kim, Thi-Hoang-Oanh Duong, JayaLakshmi Thangaraj, Tan-Huy Chu, Shin Jung, In-Young Kim, Kyung-Sub Moon, Young-Jin Kim, Tae-Kyu Lee, Chul Won Lee, Hyosuk Yun, Je-Jung Lee, Hyun-Ju Lee, Kyung-Hwa Lee, Tae-Young Jung
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
natural killer cells
bevacizumab
irinotecan
U87 cell line
glioblastoma
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1009484/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1009484/full

Similar Items